• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高表达的 miR-145 通过调节 Smad3 抑制 RANKL 诱导的骨髓来源巨噬细胞和去卵巢小鼠的破骨细胞生成。

Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.

机构信息

Department of Orthopedic, the 309th Hospital of PLA, Beijing 100091, China.

Department of Orthopedic, the 309th Hospital of PLA, Beijing 100091, China.

出版信息

Life Sci. 2018 Jun 1;202:11-20. doi: 10.1016/j.lfs.2018.03.042. Epub 2018 Mar 22.

DOI:10.1016/j.lfs.2018.03.042
PMID:29577879
Abstract

BACKGROUND

MicroRNAs (miRs) play an important role in osteoclastogenesis. However, no study has investigated the underlying molecular mechanisms of miR-145 in this process. The purpose of the present study was to investigate the role of miR-145 and its post-transcriptional mechanism in the progression of osteoclast differentiation.

METHODS

Macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor-kB ligand (RANKL) were used to induce osteoclastogenesis originated from bone marrow-derived macrophages (BMMs). Female C57BL/6J mice were divided into sham, OVX, OVX + NC-agomir and OVX + miR-145-agomir groups. Tartrate-resistant acid phosphatase (TRAP) staining was performed to identify osteoclasts in-vitro and in-vivo. The mRNA and protein levels in osteoclast and tibia were assayed by qRT-PCR and western blotting, respectively.

RESULTS

miR-145 expression was inhibited in RANKL-induced osteoclastogenesis, whereas overexpression of miR-145 attenuated it. We further found that Smad3 is a direct target gene of miR-145 by binding with its 3'-UTR. Overexpression of miR-145 significantly suppressed Smad3 mRNA and protein expression. In-vivo, miR-145 agomir treatment inhibited osteoclast activity in OVX mice by inhibiting Smad3 expression.

CONCLUSION

We provide the evidence that over-expression of miR-145 could inhibit osteoclast differentiation, at least partially, by decreasing Smad3 expression.

摘要

背景

微小 RNA(miRs)在破骨细胞分化中发挥重要作用。然而,目前尚无研究探讨 miR-145 在这一过程中的潜在分子机制。本研究旨在探讨 miR-145 在破骨细胞分化进展中的作用及其转录后机制。

方法

巨噬细胞集落刺激因子(M-CSF)和核因子κB 受体激活配体(RANKL)用于诱导骨髓来源巨噬细胞(BMMs)来源的破骨细胞分化。雌性 C57BL/6J 小鼠分为假手术组、去卵巢组、去卵巢+阴性对照 agomir 组和去卵巢+miR-145 agomir 组。体外和体内通过抗酒石酸酸性磷酸酶(TRAP)染色鉴定破骨细胞。通过 qRT-PCR 和 Western blot 分别检测破骨细胞和胫骨中的 mRNA 和蛋白水平。

结果

miR-145 在 RANKL 诱导的破骨细胞分化中受到抑制,而过表达 miR-145 则减弱了这种抑制作用。我们进一步发现 Smad3 是 miR-145 的直接靶基因,通过与 3'-UTR 结合。miR-145 的过表达显著抑制了 Smad3 的 mRNA 和蛋白表达。在体内,miR-145 agomir 处理通过抑制 Smad3 表达抑制了 OVX 小鼠的破骨细胞活性。

结论

我们提供的证据表明,通过降低 Smad3 表达,过表达 miR-145 可部分抑制破骨细胞分化。

相似文献

1
Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.高表达的 miR-145 通过调节 Smad3 抑制 RANKL 诱导的骨髓来源巨噬细胞和去卵巢小鼠的破骨细胞生成。
Life Sci. 2018 Jun 1;202:11-20. doi: 10.1016/j.lfs.2018.03.042. Epub 2018 Mar 22.
2
miRNA-340 inhibits osteoclast differentiation via repression of MITF.微小RNA-340通过抑制小眼畸形相关转录因子来抑制破骨细胞分化。
Biosci Rep. 2017 Jul 20;37(4). doi: 10.1042/BSR20170302. Print 2017 Aug 31.
3
miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.微小RNA-214通过靶向磷酸酶和张力蛋白同源物/磷脂酰肌醇-3-激酶/蛋白激酶B信号通路促进破骨细胞生成。
RNA Biol. 2015;12(3):343-53. doi: 10.1080/15476286.2015.1017205.
4
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
5
The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.天然小分子化合物蛇床子素通过抑制破骨细胞分化来预防去卵巢诱导的小鼠骨丢失。
Menopause. 2018 Dec;25(12):1459-1469. doi: 10.1097/GME.0000000000001150.
6
miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.miR-128 在小鼠破骨细胞生成和雌激素缺乏诱导的骨丢失中发挥关键作用。
Theranostics. 2020 Mar 4;10(10):4334-4348. doi: 10.7150/thno.42982. eCollection 2020.
7
CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice.环状 RNA_28313/miR-195a/CSF1 轴调节破骨细胞分化,影响去卵巢诱导的小鼠骨吸收。
RNA Biol. 2019 Sep;16(9):1249-1262. doi: 10.1080/15476286.2019.1624470. Epub 2019 Jun 19.
8
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
9
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.马粟酸通过调节 RANKL 介导的 NF-κB 和 MAPK 信号通路抑制破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
10
Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.甲基磺酰甲烷通过抑制NF-κB和STAT3活性来抑制RANKL诱导的骨髓巨噬细胞破骨细胞生成。
PLoS One. 2016 Jul 22;11(7):e0159891. doi: 10.1371/journal.pone.0159891. eCollection 2016.

引用本文的文献

1
Lithium-doped calcium silicate scaffolds-activated M2-polarized macrophage-derived miR-145-5p-riched extracellular vesicles to enhance osteoimmunomodulation for accelerating bone regeneration.锂掺杂硅酸钙支架激活M2极化巨噬细胞衍生的富含miR-145-5p的细胞外囊泡,以增强骨免疫调节作用,加速骨再生。
J Nanobiotechnology. 2025 Aug 25;23(1):586. doi: 10.1186/s12951-025-03679-2.
2
Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models.黄腐酚可减轻体外和体内糖尿病模型中TXNIP介导的肾小管损伤。
J Nat Med. 2025 Mar;79(2):314-327. doi: 10.1007/s11418-024-01863-6. Epub 2025 Jan 3.
3
Molecular Signaling Pathways and MicroRNAs in Bone Remodeling: A Narrative Review.
骨重塑中的分子信号通路与微小RNA:一篇综述
Diseases. 2024 Oct 12;12(10):252. doi: 10.3390/diseases12100252.
4
Cyclin-dependent kinase 5 as a potential therapeutic target to alleviate high glucose-induced podocyte apoptosis and hyperglycemia-induced renal injury in mice.细胞周期蛋白依赖性激酶5作为缓解小鼠高糖诱导的足细胞凋亡和高血糖诱导的肾损伤的潜在治疗靶点。
Histol Histopathol. 2025 Jan;40(1):101-112. doi: 10.14670/HH-18-764. Epub 2024 May 17.
5
miR-149-5p mitigates tumor necrosis factor-α-induced chondrocyte apoptosis by inhibiting TRADD.微小RNA-149-5p通过抑制肿瘤坏死因子受体相关死亡结构域蛋白减轻肿瘤坏死因子-α诱导的软骨细胞凋亡。
Arch Med Sci. 2020 Jan 17;20(2):602-611. doi: 10.5114/aoms.2020.92324. eCollection 2024.
6
Involvement of PI3K/Akt/β-catenin signaling in schisandrin B-mitigated bone deterioration in an experimental rat model of estrogen deficiency.PI3K/Akt/β-连环蛋白信号通路参与五味子醇甲减轻雌激素缺乏实验大鼠模型骨退化的过程。
Arch Med Sci. 2020 Feb 11;19(5):1520-1529. doi: 10.5114/aoms.2020.92873. eCollection 2023.
7
miR-372-3p is a potential diagnostic factor for diabetic nephropathy and modulates high glucose-induced glomerular endothelial cell dysfunction via targeting fibroblast growth factor-16.微小RNA-372-3p是糖尿病肾病的潜在诊断因子,通过靶向成纤维细胞生长因子-16调节高糖诱导的肾小球内皮细胞功能障碍。
Arch Med Sci. 2019 Nov 11;19(3):703-716. doi: 10.5114/aoms.2019.89659. eCollection 2023.
8
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.自发性破骨细胞生成,晚期腔面A型乳腺癌患者发生骨转移的一个风险因素。
Front Oncol. 2023 Feb 20;13:1073793. doi: 10.3389/fonc.2023.1073793. eCollection 2023.
9
Hypoxia Pathway in Osteoporosis: Laboratory Data for Clinical Prospects.骨质疏松症中的缺氧途径:临床前景的实验室数据。
Int J Environ Res Public Health. 2023 Feb 10;20(4):3129. doi: 10.3390/ijerph20043129.
10
Hsa_circ_0017728 as an oncogene in gastric cancer by sponging miR-149 and modulating the IL-6/STAT3 pathway.通过吸附miR-149并调节IL-6/STAT3通路,hsa_circ_0017728作为胃癌中的一种癌基因发挥作用。
Arch Med Sci. 2019 Aug 20;18(6):1558-1571. doi: 10.5114/aoms.2019.87274. eCollection 2022.